ANDA 76469, held by Watson Laboratories. Cromolyn Sodium.
As of Nov 21, 2026, ANDA 76469 (Cromolyn Sodium), held by Watson Laboratories, was first approved by FDA on Jun 17, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 17, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cromolyn Sodium10MG/ML · solution;inhalation | Cromolyn Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters